Click on a filter below to refine your search. Remove a filter to broaden your search.
New premium will be $170.10 a month, and the $21.60 boost is the biggest increase ever in dollar amount, but not in percentage terms
But the biggest policy change — letting Medicare negotiate prices for prescription drugs — will not start to lower costs until 2025.
The controversy over aducanumab (Aduhelm) stretches back to its June 2021 approval by the US Food and Drug Administration.
Major changes to prescribing instructions are rare, especially so soon after approval; it change could curb the drug’s use.
The drug shows promise in clearing the brain plaques believed to play a role in Alzheimer’s disease.
Factors associated with long-distance travel include low neurologist density, rural setting and visits for ALS and nervous system cancer.